共 150 条
[1]
Poyanli A(2001)Palliative treatment of hepatocellular carcinoma by chemoembolization Acta Radiol. 42 602-607
[2]
Rozanes I(2013)Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization Clin Gastroenterol Hepatol 11 1358e.1-1365.e1
[3]
Acunas B(2006)A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates In Vivo 20 711-714
[4]
Sencer S(2015)Quality of life changes in patients undergoing treatment for hepatocellular carcinoma Qual Life Res. 24 2499-2506
[5]
Salem R(2003)Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology. 37 429-442
[6]
Gilbertsen M(2011)Hepatocellular carcinoma N Engl J Med. 365 1118-1127
[7]
Butt Z(2012)Epidemiology of viral hepatitis and hepatocellular carcinoma Gastroenterology 142 1264e.1-1273.e1
[8]
Mancini R(2007)Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone Qual Life Res. 16 389-397
[9]
Carpanese L(2012)EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol. 56 908-943
[10]
Sciuto R(2011)Management of hepatocellular carcinoma: an update Hepatology. 53 1020-1022